Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 4, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • ATF4: A stress-responsive factor in mTORC1 signaling

Oncogenic mutations in K-Ras CaM interactions

Norovirus cases double: England warned by officials

ATF4: A stress-responsive factor in mTORC1 signaling
  • BiotechToday
  • World

ATF4: A stress-responsive factor in mTORC1 signaling

BioTech Today July 27, 2021July 26, 2021

Vaishnavi Kardale, Bioinformatics Centre, Savitribai Phule Pune University

For a very long time, researchers have been searching for ways to increase human life. In this quest, they have found one promising protein -mTOR. The finding of mTOR has given rise to a whole field in cellular biology that studies mTOR and its associated pathway. 

mTOR- A CPU that responds to input:

The story begins with the finding of Rapamycin. Suren N Sehgal – widely considered the father of rapamycin was searching for new antibiotics in the soil. In 1975, he purified the compound from Easter Island also known as Rapa Nui. Initially discovered as an antifungal, its role as an immunosuppressive and an anti-cell proliferative was unknown. To understand the cellular pathway of rapamycin, David Sabatini began his work and isolated mTOR. 

Mechanistic Target of Rapamycin (mTOR) has been found to be a protein that is highly conserved. It is at the center of a lot of cellular processes. mTOR is primarily responsible for cell growth and proliferation and responds to a number of factors like nutrients, oxygen stress, fasting and feeding state, insulin levels, and growth factors. It promotes protein and lipid synthesis and suppresses autophagy. David Sabatini describes mTOR as a CPU that sits at the center that responds according to the input. 

Why mTOR?

Significant research has been found that suggests that the inhibition of mTOR can slow down aging and age-associated diseases. Its role in cell proliferation is being inspected by cancer biologists. mTOR inhibition led to longevity in model organisms. mTOR regulates many downstream cellular processes; research is being carried out to better understand them.

A Study to analyze mTORC1 signaling:

ATF4, a stress-responsive transcription factor, was found to be regulated by mTORC1 signaling in growing cells. ATF4’s role was investigated to determine whether it is responsive to mTORC1 signaling to alter hepatocyte metabolism. To do this, researchers analyzed ATF4 protein levels and their canonical gene targets in the liver after physiological fasting and feeding in the presence and absence of mTORC1 inhibitor rapamycin.  To characterize the effect of insulin-stimulated mTORC1- ATF4 function on hepatocyte metabolism, hepatocytes from wild-type and liver-specific Atf4 knockout mice were used.

What did the study find?

The study found that mTORC1 signaling in the liver stimulates ATF4 and its metabolic gene target in response to feeding and insulin. The study also found that de novo purine and pyrimidine synthesis was stimulated, independent of ATF4, by insulin through mTORC1 signaling. Metabolomic studies revealed that non-essential amino acid synthesis in the liver cells was stimulated by insulin-mTORC1-ATF4 signaling. 

Conclusion:

ATF4 was found to be a novel effector of hepatic mTORC1 signaling in response to insulin. There may be more downstream mediators of the mTORC1 that are yet to be defined. This study helps us understand how mTORC1 exerts metabolic control.  It is of particular interest that in the case of obesity both ATF4 and mTORC1 are upregulated. 

Also read: Antibiotic-Resistant Bacteremia affects children with pneumonia

Reference:

  1. Byles, V., Cormerais, Y., Kalafut, K., Barrera, V., Hughes Hallett, J. E., Ho Sui, S., Asara, J. M., Adams, C. M., Hoxhaj, G., Sahra, I. B., & Manning, B. D. (2021). Hepatic mTORC1 signaling activates ATF4 as part of its metabolic response to feeding and insulin. Molecular Metabolism. Published. https://doi.org/10.1016/j.molmet.2021.101309
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Author info:

Vaishnavi Kardale is a master’s student at the Bioinformatics Centre, Savitribai Phule University. She is interested in protein folding mechanisms and wants to study them further.

  • https://bioxone.in/news/worldnews/global-warming-may-reduce-the-spread-of-dengue/
  • https://bioxone.in/news/worldnews/comeback-of-tuberculosis-but-its-drug-resistant-now/
  • https://bioxone.in/news/worldnews/a-drug-to-reduce-covid-infection-by-99/
  • https://bioxone.in/news/worldnews/artificial-intelligence-ai-for-efficient-covid-testing/
  • https://bioxone.in/news/worldnews/deephbv-a-machine-learning-tool-to-aid-in-hepatitis-b-integration-site-detection/

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Related

Tagged ageing ATF4 cell signaling hepatocyte insulin liver mTORC rapamycin

One thought on “ATF4: A stress-responsive factor in mTORC1 signaling”

  1. Pingback: Telomerase: The Quest For Reliable Cancer Therapeutics - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Norovirus cases double: England warned by officials

BioTech Today July 27, 2021

Mahek Sharan, Institute of Applied Medicines and Research, Ghaziabad Norovirus is responsible for the 200,000 deaths every year globally. It affects the population across the world including the developed or developing countries. The developed countries are more severely affected by norovirus, with a record of 50,000 deaths in the winter months. In a recent report […]

Norovirus cases

Related Post

  • BiotechToday
  • World

Tardigrade found in Miocene Dominican amber

BioTech Today October 20, 2021October 20, 2021

Ananya Ghosal, MAKAUT (WB) A tardigrade is a distinct group that comes under microscopic invertebrates, that is best suited for extreme conditions. The fossil record of a tardigrade is extremely scattered despite their global distribution and evolutionary history in the terrestrial and aquatic environment. The differentiation of tardigrades from other panarthropod lineages was estimated by […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • World

Science and technology help in simplifying tumour testing

bioxone October 14, 2020October 13, 2020

Camelia Bhattacharyya, Amity University Kolkata We live in a world that needs more fast methods to be used from day-to-day problems to higher or complicated forms of problems; the healthcare system is not excluded from these. Patients are needing immediate treatment after quick testing which mostly depends on the equipment and the techniques used. This […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • BiotechToday
  • Latest
  • World

Sudden Death Syndrome in Soybean can be controlled by Trichoderma sp.

bioxone September 5, 2020September 5, 2020

-Sanket Roy, Amity University Kolkata Fusarium virguliforme causes the most catastrophic disease in Soybean named Sudden death syndrome (SDS) which destructs almost 80% of the total yield under favorable growth conditions. To deal with the disastrous infection, a group of scientists from Southern Illinois University, University of Iowa and Syngenta Crop Protection have come up […]

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy